Traditional sacral neuromodulation devices are not rechargeable. In recent years, new rechargeable sacral neuromodulation devices have been developed and put into the market. The aim of this study was to evaluate the cost savings of a rechargeable sacral neuromodulation device versus a non-rechargeable sacral neuromodulation device for the treatment of neurogenic lower urinary tract dysfunction.
male and female patients with neurogenic lower urinary tract dysfunction who had failed conventional treatment
obstructive urinary retention and contraindications to SNM
None
They were treated with rechargeable or non-rechargeable sacral neuromodulation devices
Case-control
Retrospective
Not listed
Costs associated with sacral neuromodulation therapy
Costs associated with sacral neuromodulation therapy
Click on the lead sponsor to view all of their trials.
Qilu Hospital of Shandong University
Lead sponsor
Aerospace Center Hospital
Collaborator
Shandong Provincial Hospital
Collaborator
Second Affiliated Hospital of Xi'an Jiaotong University
Collaborator
Beijing Hospital
Collaborator
Xi'an Honghui Hospital
Collaborator
The First Affiliated Hospital of Zhengzhou University
Collaborator
Second Hospital of Jilin University
Collaborator
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Collaborator
Tongji Hospital
Collaborator
This trial is not recruiting at the moment. You can still explore other options:
